Spunbond Nonwoven Market Trends in 2021, Size, Share, Industry Growth Impact, Key Drivers and Forecast to 2028 | Fortune Business Insights™

 The global Spunbond Nonwoven Market analysis is estimated to rise remarkably in the coming years on account of the increasing demand from the automotive sector worldwide. Spunbond is the process of producing nonwoven fabric by continuously spinning filament fibers into a moving belt.  A recent report by Fortune Business Insights, titled, “Spunbond Nonwoven Market Size, Share & Industry Analysis, By Type (Polyester, Polypropylene, Polyethylene), By End-Use Industries (Personal Care & Hygiene, Medical, Agriculture, Packaging, Automotive, Others) Others and Regional Forecast, 2019-2028,” offers insights into the market and a complete analysis of the same.
Objectives of the Report:
The report provides a comprehensive overview of the market and throws light on the growth drivers, restraints, challenges and upcoming opportunities. It also discusses the major industry developments of the market and current trends. Besides this, the report provides the table of segmentation in detail, names of the leading segments and their attributed factors. For more information on the report, log on to the company website.
Drivers & Restraints-
Increasing Demand for Polypropylene Nonwovens to Augment Growth
Spunbond is a porous fabric made up of long fibers, plastic films or molten plastic and possesses unique qualities such as chemical and heat resistance, porous nature, and burst strength. They are also used for making boot carpets, heat shields, molded bonnet liners, hood insulation, airbags, carpet and flooring seats, and other products. The increasing demand from the automotive industry is a key factor boosting the global spunbond nonwoven market growth. Besides this, the rising demand for polypropylene spunbond nonwovens will also add impetus to the market in the coming years.
On the contrary, the high cost of the finished product may pose a major challenge to the market in the coming years. This, coupled with the volatility in the price of raw materials may also cause hindrance to the market in the forecast period.
Nevertheless, the increasing use of spunbond nonwovens in the healthcare sector, increasing standard of living, and the rising demand for geotextiles are expected to create lucrative growth opportunities for the market in the coming years.

Some of the Key Players of the Spunbond Nonwoven Market include:
RadiciGroup SpA, Avgol Ltd.,
Kimberly-Clark Corporation
PFNonwovens Czech s.r.o.
Mitsui Chemicals, Inc.
Asahi Kasei Corporation
Schouw & Co.
Kuraray Co., Ltd.
Toray Industries, Inc.
Fitesa S.A.
Berry Plastics Group, Inc.
Johns Manville Corporation
The Market for Spunbond Nonwoven is Classified into the Following:
The global spunbond nonwoven market is categorized on the basis of type, end use industries, and region. Based on type, the market is classified into polyester, polypropylene, and polyethylene. With respect to end-use industries, the market is grouped into automotive, packaging, agriculture, medical, personal care & hygiene, and others.
Regional Analysis-
Asia Pacific Held Largest Share Owing to Growing Inclination towards Personal Care products 
Asia Pacific held the highest spunbond nonwoven market share in 2018 owing to the rising inclination of people towards personal care products. Japan, India, and China are the leading nations in this market. North America will exhibit significant growth in the coming years on account of a rise in the demand for polypropylene for use in the production of goods for personal hygiene. This is further attributed to the chemical resistance, tensile strength, and temperature tolerant properties of polypropylene.
Additionally, the Europe market will also generate notable growth in the forecast period on account of the increasing demand from the healthcare sector. Furthermore, the market in Latin America will be driven by the increasing investment by the government and private companies in real estate infrastructure and the growing demand for manufacturing geotextiles used in construction activities.
Cards you may also be interested in
Zeo Taxi Pages List for Taxi Booking #travel #cabs #carrental #taxiservice #cabservice #taxiservices #cabservices #taxibooking #cabbooking #carhire #taxihire #cabhire #carbooking #taxirental #cabrental #zeotaxi #cabonhire #taxionhire #booktaxi
Therapeutic Drug Monitoring Market - Industry Growth, Dynamics, Segmentation and Forecast
According to the new market research report “Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User – Global Forecast to 2025″, published by MarketsandMarkets™, the TDM Market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.9% from 2020 to 2025. Growth Driver: Importance of TDM in Organ Transplant Procedures; Conducting TDM for immunosuppressive medications is an essential tool in the management of patients undergoing solid organ transplantation. A person receiving an organ transplant is prescribed immunosuppressants so that the body does not reject the organ. When administering immunosuppressants, clinicians need to individualize a patient’s drug therapy and ensure an optimal balance between therapeutic efficacy and the probability of adverse effects. Patients present different pharmacodynamics and pharmacokinetics, so achieving this goal with immunosuppressant therapy monitoring can be challenging. TDM is used before administering immunosuppressants as it minimizes the pharmacokinetic component of variability. Improper drug concentrations in immunosuppressants can lead to adverse effects on transplant patients. Supra-therapeutic drug concentrations can put the patient at risk of over-immunosuppression, which may cause infection. On the other hand, sub-therapeutic drug concentrations can cause the recipient’s body to reject an allograft. This inter-individual variability in drug concentrations creates the need for TDM. Download PDF Brochure: North America commanded the largest share of the therapeutic drug monitoring market in 2019. Geograpgically, Segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America commanded the largest share of the market. Increasing per capita healthcare expenditure and the presence of technologically advanced healthcare infrastructure in the region, coupled with initiatives taken by different government associations, are anticipated to boost the market growth in the region. The major players operating in this therapeutic drug monitoring market are Abbott Laboratories (U.S.), F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux (France), BÜHLMANN Laboratories (Switzerland), SEKISUI MEDICAL (Japan), Randox Laboratories (Ireland), DiaSystem Scandinavia AB (Sweden), Cambridge Life Sciences Limited (United Kingdom), ARK Diagnostics, Inc. (U.S.), Chromsystems Instruments & Chemicals GmbH (Germany), Grifols (Spain), Exagen Inc. (U.S.), Theradiag (France), R-Biopharm AG (Germany), apDia Group (Belgium), BioTeZ Berlin-Buch GmbH (Belgium), Eagle Biosciences Inc. (U.S.), JASEM Laboratory Systems and Solutions A.S (Turkey), Aalto Scientific (U.S.), Immundiagnostik AG (Germany), and UTAK (U.S.). Request Sample Pages: Immunoassays is expected to hold the largest share of the TDM Market in 2020 Based on technology, segmented into immunoassays and chromatography-MS. In 2019, immunoassays segment accounted for the largest market share, due to the increasing incidence of chronic and infectious diseases and technological innovation. Antiepileptic drugs is expected to hold the largest share of the therapeutic drug monitoring market in 2020 On the basis of class of drug, the TDM Market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs. During 2019, antiepileptic drugs held the largest share among the class of drug due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs. Hospital laboratories segment commanded the largest share of the TDM Market in 2019 By end user, the Therapeutic Drug Monitoring Market is segmented into hospital laboratories, commercial & private laboratories, and other end users. Hospital laboratories accounted for the largest share of the market in 2019. The large share of this segment can be attributed to factors such as the availability of advanced healthcare facilities in hospitals and the rising incidences of chronic diseases. Speak to Analyst: